Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AZD-5863 by AstraZeneca for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
AZD-5863 is under clinical development by AstraZeneca and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...
AZD-5863 by AstraZeneca for Gastric Cancer: Likelihood of Approval
AZD-5863 is under clinical development by AstraZeneca and currently in Phase II for Gastric Cancer. According to GlobalData, Phase II...
AZD-5863 by AstraZeneca for Solid Tumor: Likelihood of Approval
AZD-5863 is under clinical development by AstraZeneca and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
AZD-5863 by AstraZeneca for Esophageal Cancer: Likelihood of Approval
AZD-5863 is under clinical development by AstraZeneca and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II...
AZD-5863 by AstraZeneca for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
AZD-5863 is under clinical development by AstraZeneca and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction. According to...